Severe contact esophagitis in a patient taking crizotinib: A case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Severe contact esophagitis in a patient taking crizotinib: A case report

Published:2015-04-09 Issue:2 Volume:11 Page:187-189
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Conduit Ciara¹,Wilson Mark²,Hunter Karen³,Murdolo Vince⁴,Nott Louise¹

Affiliation:

1. Department of Medical Oncology; Royal Hobart Hospital; Hobart Tasmania Australia

2. Department of Gastroenterology; Royal Hobart Hospital; Hobart Tasmania Australia

3. Department of Pharmacy; Royal Hobart Hospital; Hobart Tasmania Australia

4. Department of Pathology; Royal Hobart Hospital; Hobart Tasmania Australia

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12341/fullpdf

Reference10 articles.

1. Crizotinib versus chemotherapy in advanced ALK-Positive lung cancer;Shaw;N Engl J Med,2013

2. Activity and safety of crizotinib in patients with ALK-positive on-small-cell-lung cancer: updated results from a phase 1 study;Camidge;Lancet Oncol,2012

3. Kim D Bang Y Kwak E et al Results of a global phase II study with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC) 2012

4. Crizotinib-induced esophageal ulceration: a novel adverse event of crizotinib;Park;Lung Cancer,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medication‐Induced Esophageal Injury;The Esophagus;2021-04-30

2. Crizotinib-induced erosive esophagitis in a pediatric patient with neuroblastoma;Journal of Oncology Pharmacy Practice;2018-01-22

3. Meta-analysis of incidence and risk of severe adverse events and fatal adverse events with crizotinib monotherapy in patients with ALK-positive NSCLC;Oncotarget;2017-06-17

4. Second- and third-generation ALK inhibitors for non-small cell lung cancer;Journal of Hematology & Oncology;2016-03-08

5. Severe Erosive Pill Esophagitis Induced by Crizotinib Therapy: A Case Report and Literature Review;Case Reports in Gastrointestinal Medicine;2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3